Is Trends in Molecular Medicine Indexed in PubMed? Yes, With Active MEDLINE Indexing
Trends in Molecular Medicine is indexed in PubMed and currently indexed for MEDLINE, with coverage from volume 7, issue 1 in January 2001 under the current title.
Next step
Choose the next useful decision step first.
Use the guide or checklist that matches this page's intent before you ask for a manuscript-level diagnostic.
Trends in Molecular Medicine at a glance
Key metrics to place the journal before deciding whether it fits your manuscript and career goals.
What makes this journal worth targeting
- IF 13.8 puts Trends in Molecular Medicine in a visible tier — citations from papers here carry real weight.
- Scope specificity matters more than impact factor for most manuscript decisions.
- Acceptance rate of ~~10-20% means fit determines most outcomes.
When to look elsewhere
- When your paper sits at the edge of the journal's stated scope — borderline fit rarely improves after submission.
- If timeline matters: Trends in Molecular Medicine takes ~~60-90 days median. A faster-turnaround journal may suit a grant or job deadline better.
- If open access is required by your funder, verify the journal's OA agreements before submitting.
Quick answer: yes. Trends in Molecular Medicine is indexed in PubMed and currently indexed for MEDLINE from volume 7, issue 1 in January 2001, the start of the current title. The NLM record also shows that it continues Molecular Medicine Today, which matters because many authors want to know whether the current review journal has a clean discoverability story or a messy title-history gap. It is clean.
Direct answer
If you publish a review or perspective in Trends in Molecular Medicine, the article is discoverable in PubMed and the journal remains inside the active MEDLINE system.
NLM field | What the record shows | Why it matters |
|---|---|---|
current-title start year | 2001 | indexing for the present title begins at launch |
PubMed coverage | v7n1, Jan. 2001- | current-title content is searchable from the first issue |
MEDLINE coverage | v7n1, Jan. 2001- | curated NLM indexing also starts with the current title |
current indexing status | Currently indexed for MEDLINE | active inclusion, not archive-only status |
current subset | Index Medicus | the title sits in the standard biomedical indexing structure |
title continuity | Continues Molecular Medicine Today | helps explain the current-title numbering and continuity |
That is a clean indexing record for a review-led translational medicine journal.
Why this matters for Trends in Molecular Medicine
The strongest pieces in Trends in Molecular Medicine are not primary-data papers trying to win on one narrow experiment. They are usually synthesis or forward-looking articles that need to reach:
- translational researchers
- clinician-scientists
- lab heads surveying a fast-moving mechanism
- trainees entering a disease or pathway area
- grant, review, and perspective authors building a field map
Those readers usually search by pathway, target class, disease biology, modality, or translational bottleneck. They do not depend on browsing one journal issue. PubMed indexing matters because it is how a review-led journal earns practical usefulness after publication.
What the indexing record tells you in practice
Practical question | What the record tells you |
|---|---|
will a published article surface in normal biomedical search? | yes |
is the title actively indexed for MEDLINE? | yes |
does the current title start with clean indexing continuity? | yes |
is there title-history context to understand? | yes, it continues Molecular Medicine Today |
does that prove your article belongs here? | no |
That last line is the one authors usually need to keep separate.
PubMed versus MEDLINE for a review-led translational journal
For Trends in Molecular Medicine, the distinction still matters:
- PubMed means the article is visible in the main biomedical search interface.
- MEDLINE means the title remains inside the curated NLM journal index.
For a journal built around review and perspective pieces, that combination matters because discoverability is part of the product. If a synthesis article cannot be found quickly when readers are orienting to a problem, much of its value disappears.
How title continuity affects interpretation
This page is slightly more interesting than a plain yes-or-no indexing check because the current title continues Molecular Medicine Today.
Title-history question | Practical interpretation |
|---|---|
does the current title have its own clean indexing start? | yes, January 2001 |
should authors worry that the numbering looks inherited? | only enough to understand the continuation |
does the continuation weaken current discoverability? | no |
That is the useful nuance. The continuation explains the numbering, but it does not create a discoverability problem for the current title.
How this compares with nearby review journals
Journal pattern | What indexing usually supports | What it does not settle |
|---|---|---|
review-led translational title like Trends in Molecular Medicine | strong topic-driven discoverability | whether the framing is sharp enough for this editorial model |
high-prestige review title | broad visibility and strong brand carry | whether your synthesis is important enough |
specialty review journal | good niche discoverability | whether you need a broader translational readership |
That is why indexing is useful here, but limited. It answers whether the article will be findable. It does not answer whether the journal is the right review venue.
How to verify the record yourself
To check the indexing manually:
- open the NLM Catalog record
- confirm the PubMed line
- confirm the MEDLINE line
- confirm Current Indexing Status
- note the continuation from Molecular Medicine Today
- run a direct journal-title search in PubMed
For this title, that continuity detail is the one extra thing worth checking because it explains the current-title record cleanly.
In Our Pre-Submission Review Work on PubMed-Indexing Questions for Trends in Molecular Medicine
In our pre-submission review work on PubMed-indexing questions for Trends in Molecular Medicine, three patterns come up repeatedly.
The review-journal visibility worry. Authors sometimes assume a review-led journal may matter mostly through reputation and not through search. For this title, that is the wrong framing. The record is clean, active, and built for search-driven reuse.
The title-history confusion. Another common question is whether the continuation from Molecular Medicine Today creates a weak or partial indexing story. It does not. The current title has clear PubMed and MEDLINE coverage from its first issue in 2001.
The indexing-equals-fit shortcut. We also see teams treat strong discoverability as proof that a review or perspective belongs here. It does not. The harder issue is whether the article offers enough synthesis value, translational framing, and field-level usefulness.
That is the real information gain here. The indexing answer is clean. The editorial-fit answer is still separate.
What the NLM record means in practice for authors
The useful thing about the Trends in Molecular Medicine record is that it removes ambiguity. Current-title coverage begins at launch, MEDLINE status is active, and the continuation note explains the history without weakening discoverability.
For authors, that means the database-status question is easy to close. If a review or perspective is accepted here, readers will find it through normal topic-driven PubMed searches.
The harder strategic question is different: is the piece broad enough, useful enough, and translational enough for a Trends journal rather than a narrower disease or mechanism review venue?
What indexing does and does not tell you
This page answers the discoverability question. It does not answer whether your piece belongs in Trends in Molecular Medicine.
Indexing tells you:
- the published article will be visible in PubMed
- the journal is actively indexed for MEDLINE
- the current title has clean indexing continuity from launch
Indexing does not tell you:
- whether the article offers enough synthesis value
- whether the translational framing is sharp enough
- whether another review venue would match the audience better
That is why the better next reads are:
- Trends in Molecular Medicine acceptance rate
- Trends in Molecular Medicine submission guide
- Trends in Molecular Medicine journal overview
If the fit question is what you actually need answered, a Trends in Molecular Medicine submission readiness check gives you a manuscript-specific signal before you submit.
Submit If / Think Twice If
Use this indexing answer as enough reassurance if:
- your main concern is whether a published review will be easy to find
- you want confirmation of active MEDLINE indexing for the current title
- you need clarity on the current-title continuation from Molecular Medicine Today
Think twice if:
- you are using indexing as a proxy for editorial fit
- the piece may still be too narrow or too descriptive for this review journal
- what you really need is a framing and article-type judgment instead
Readiness check
Run the scan while the topic is in front of you.
See score, top issues, and journal-fit signals before you submit.
Practical verdict
Yes, Trends in Molecular Medicine is indexed in PubMed and currently indexed for MEDLINE, with current-title coverage beginning in January 2001 and clean continuity from Molecular Medicine Today.
If your question is whether a published review or perspective will be visible in the biomedical literature workflow, the answer is yes. If your real question is whether the article type and translational framing are right for the journal, that is the harder fit call. A Trends in Molecular Medicine submission readiness check is the best next step if you want that answer before submission.
Frequently asked questions
Yes. Trends in Molecular Medicine is indexed in PubMed and currently indexed for MEDLINE according to the NLM Catalog.
The NLM Catalog shows PubMed and MEDLINE coverage from volume 7, issue 1 in January 2001, which matches the current title's launch and continuation of Molecular Medicine Today.
Because review and perspective pieces in molecular medicine are often discovered by disease, pathway, or translational-problem search rather than by direct journal browsing. PubMed keeps those pieces findable when readers need them.
Open the journal's NLM Catalog record, check the current indexing status plus the PubMed and MEDLINE lines, and confirm recent articles appear normally in PubMed.
Sources
- 1. Trends in Molecular Medicine NLM Catalog record, NLM.
- 2. NLM Catalog help: current indexing status, NLM.
- 3. Trends in Molecular Medicine journal page, Cell Press.
- 4. Trends journal author information, Cell Press.
- 5. Trends in Molecular Medicine in PubMed, PubMed.
Before you upload
Choose the next useful decision step first.
Move from this article into the next decision-support step. The scan works best once the journal and submission plan are clearer.
Use the scan once the manuscript and target journal are concrete enough to evaluate.
Anthropic Privacy Partner. Zero-retention manuscript processing.
Where to go next
Same journal, next question
- Trends in Molecular Medicine Submission Guide: What the Journal Actually Wants
- How to Avoid Desk Rejection at Trends in Molecular Medicine
- Trends in Molecular Medicine Under Review: What the Status Means
- Trends in Molecular Medicine Review Time: What Authors Can Actually Expect
- Trends in Molecular Medicine Cover Letter: What Editors Actually Need to See
- Trends in Molecular Medicine Impact Factor 2026: 13.8, Q1, Rank 4/195
Supporting reads
Conversion step
Choose the next useful decision step first.
Use the scan once the manuscript and target journal are concrete enough to evaluate.